CTT Pharmaceutical Holdings, Inc. income statement CTTH

Annual Quarterly

It recorded a net loss of $672,162.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line	FY 2026 Jun 30, 2026	FY 2014 Dec 31, 2014	FY 2013 Dec 31, 2013	FY 2012 Dec 31, 2012	FY 2011 Dec 31, 2011
Selling, general and administrative	—	0 +358.9%	0 -97.6%	0 -50.0%	0
Operating income	—	-1 -3454.3%	-0 +98.4%	-1 -57.7%	-1
Net income	—	-1 -3454.3%	-0 +98.1%	-1 -126.8%	4
Basic EPS	—	—	0.01 +109.1%	-0.11 -126.2%	0.42
Diluted EPS	—	—	0.01 +109.1%	-0.11 -127.5%	0.40
Weighted average shares, basic	—	—	9 +0.0%	9 +5.5%	9
Weighted average shares, diluted	—	—	9 +0.0%	9 -0.8%	9
Other measures
Depreciation and amortization	—	—	—	—	0
EBITDA	—	—	—	—	-1

How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. The first column is the trailing twelve months through the latest quarter. More on our methodology.

New to this? Read How to Read an Income Statement, With a Real Example.

Company profile

Industry: Pharmaceutical Preparations (SIC 2834)
Listed as: CTTH (OTC)
Fiscal year ends: December 31
Incorporated in: FL
Headquarters: Tampa, FL
SEC filer status: Non-accelerated filer, Smaller reporting company, Emerging growth company
SEC CIK: 1035422
Former names: Mindesta Inc. (until Jul 21, 2015); INDUSTRIAL MINERALS INC (until Jul 18, 2011); PNW CAPITAL INC (until May 21, 2002); WINCHESTER MINING CORP (until May 26, 2000)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.